Tag: 探探上约多少钱一晚

Gardner 1050 / Lorcan O’Herlihy Architects

first_img “COPY” ArchDaily CopyApartments•West Hollywood, United States Gardner 1050 / Lorcan O’Herlihy ArchitectsSave this projectSaveGardner 1050 / Lorcan O’Herlihy Architects Gardner 1050 / Lorcan O’Herlihy Architects ShareFacebookTwitterPinterestWhatsappMailOrhttps://www.archdaily.com/23336/gardner-1050-lorcan-o%25e2%2580%2599herlihy-architects Clipboard CopyAbout this officeLorcan O’Herlihy ArchitectsOfficeFollowProductsWoodGlassConcrete#TagsProjectsBuilt ProjectsSelected ProjectsResidential ArchitectureHousingApartmentsWest HollywoodWoodHousingUnited StatesPublished on May 29, 2009Cite: “Gardner 1050 / Lorcan O’Herlihy Architects” 29 May 2009. ArchDaily. Accessed 12 Jun 2021. ISSN 0719-8884Read commentsBrowse the CatalogPanels / Prefabricated AssembliesTechnowoodSiding Façade SystemWindowsMitrexSolar WindowMetal PanelsAurubisCopper Surface: Nordic DécorDining tablesB&B ItaliaDining Table – BullSkylightsVELUX CommercialModular Skylights – Atrium Longlight / RidgelightLouvers / ShuttersBruagShading Screens – Perforated Facade PanelsConcreteKrytonSmart ConcreteCompositesPure + FreeFormTechnical Guide – Creating a Seamless Interior and Exterior Material TransitionEnclosures / Double Skin FacadesFranken-SchotterFacade System –  LINEAWindowsRabel Aluminium SystemsMinimal Casement Windows – Rabel 8400 Slim Super Thermal PlusDoorsGorter HatchesFloor Door – Fire RatedWire MeshCarl Stahl DecorCableGreen Wall System – FAÇADESCAPE™More products »Read commentsSave世界上最受欢迎的建筑网站现已推出你的母语版本!想浏览ArchDaily中国吗?是否翻译成中文现有为你所在地区特制的网站?想浏览ArchDaily中国吗?Take me there »✖You’ve started following your first account!Did you know?You’ll now receive updates based on what you follow! Personalize your stream and start following your favorite authors, offices and users.Go to my stream 2006 Projects ShareFacebookTwitterPinterestWhatsappMailOrhttps://www.archdaily.com/23336/gardner-1050-lorcan-o%25e2%2580%2599herlihy-architects Clipboard Apartments Year:  Architects: Lorcan O’Herlihy Architects Year Completion year of this architecture project “COPY” Save this picture!+ 14 Share Text description provided by the architects. As a model of courtyard housing development, Gardner 1050 utilizes a variety of design strategies to elevate it above the more mundane infill developments typical of speculative housing. The project’s location just south of Santa Monica Boulevard creates a unique opportunity to add to the burgeoning urbanism of the eastern section of West Hollywood.Save this picture!Recommended ProductsGlassSolarluxGlass Canopy – SDL AcubisEnclosures / Double Skin FacadesFranken-SchotterFacade System –  LINEAEnclosures / Double Skin FacadesRodecaRound Facade at Omnisport Arena ApeldoornSkylightsKalwall®Skyroofs® – Specialty Skyroof® ApplicationsLandscaped with native drought-tolerant species, stainless-steel cables creep up to the third level walkways forming scaffolding for a “hanging” garden. This vertical foliage offers a peaceful respite in a courtyard that opens to the sky. On the western (front) facade, the cut-away box is completed by a semi-transparent skin of cedar slats enveloping the courtyard and completing the corner at the garage entry.Save this picture!The stair is clad in translucent glass provides a strong vertical element in an otherwise predominantly horizontal composition. This stair functions as an entry marker and provides a subdued lantern like quality at night further enhancing the overall quality of the project. Save this picture!The primary materials for the project consist of a painted cement board cladding system in four foot wide panels, a system of cedar wood slats, translucent channel glass panels, and painted aluminum window frame projections in three colors. The horizontal wood slats encompass the entire second floor.Save this picture!By wrapping the units around a central courtyard, the project consists of 10 unique and distinct floor plans as opposed to the conventional approach of identically stacked units. This central courtyard weaves buildings’ circulation into a spectrum of public space, while also allowing all units to have direct access from the exterior, eliminating the need for mechanically climate controlled corridors.Save this picture!Project gallerySee allShow lessVertical Park / Jorge Hernandez de la GarzaArticlesZaha Hadid announces new project for CairoArticlesProject locationAddress:West Hollywood, CA, USALocation to be used only as a reference. It could indicate city/country but not exact address. Share United Stateslast_img read more

Read More

Algerian journalist beaten by plainclothes police

first_img News Forum on Information and Democracy 250 recommendations on how to stop “infodemics” Receive email alerts TunisiaMiddle East – North Africa Eleven organizations from civil society create the Forum on Information & Democracy, a structural response to information disorder November 12, 2019 Find out more News Help by sharing this information Tunisia : RSF asks Tunisian president’s office to respect journalists RSF_en Newscenter_img December 26, 2019 Find out more May 6, 2002 – Updated on January 20, 2016 Algerian journalist beaten by plainclothes police to go further Follow the news on Tunisia November 11, 2020 Find out more Organisation TunisiaMiddle East – North Africa News Reporters Without Borders (Reporters sans frontières – RSF) protested today against a physical attack by Tunisian police on Algerian journalist Mohamed Ioua Noughene, of the daily paper El Khabar.”The Tunisian authorities are disgracefully taking advantage of the international media’s focus on Israel and the French presidential election to resume their attacks against regime opponents and journalists,” said RSF secretary-general Robert Ménard in a letter to Tunisian interior minister Hedi M’henni. RSF notes that over the past year, three journalists, one of them French, have been physically attacked by Tunisian police.RSF learns that a May Day meeting in Tunis organised by the underground weekly Kaws el-Karama could not be held because large numbers of police barred access to the meeting hall. As people saw this and left the area, Noughene was set upon by five plainclothes police who beat him up even though he told them he was an Algerian journalist. Three Tunisian trade unionists who tried to help him were also beaten and one, Fathi Debak, was taken to a nearby wood and severely beaten.A few hours earlier, police moved to disperse several hundred people who had gathered in Mohammed Ali Square, in Tunis, to celebrate May Day and show support for the Palestinians. A plainclothes policeman threw a tear-gas grenade – deliberately, according to witnesses – at Jalel Zoghlami, managing editor of Kaws el-Karama, and two trade unionists.last_img read more

Read More

Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA…

first_img WhatsApp WhatsApp By Digital AIM Web Support – February 8, 2021 Facebook Facebook Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL Previous articleMcCormack helps unranked KU beat No. 23 Oklahoma St. 78-66Next articleCirelli scores twice as Tampa Bay beats Predators 4-1 Digital AIM Web Support BASEL, Switzerland–(BUSINESS WIRE)–Feb 8, 2021– Rhizen Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company, today announced that its novel next generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeutics (NASDAQ:TGTX), has secured US FDA accelerated approval for the treatment of: adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20 based regimen, andadult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy. Accelerated approval was granted for these indications, under a priority review (MZL), based on the results of the Phase 2 UNITY-NHL Trial (NCT02793583); in MZL, an ORR of 49% with 16% complete responses and in FL an ORR of 43% with 3% complete responses were achieved, respectively. Umbralisib was earlier granted Breakthrough Therapy Designation (BTD) for the treatment of MZL and orphan drug designation (ODD) for the treatment of MZL and FL. Umbralisib is a novel, next generation, oral, once daily, inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1 (CK1) epsilon and was discovered by Rhizen Pharma and subsequently licensed to TG Therapeutics (NASDAQ:TGTX) at an IND stage (TGR 1202) in 2012. In 2014, both parties entered into a licensing agreement as a part of which TGTX obtained worldwide rights and Rhizen has retained commercialization rights for India while also being the manufacturing and supply partner for Umbralisib. Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said: “Umbralisib’s approval offers MZL & FL patients a new treatment option and is a huge validation of Rhizen’s drug discovery & development capabilities. This is a momentous occasion in Rhizen’s journey as a successful biotech that speaks of the true ability of our team to discover & develop safe and effective therapies that can last the rigors of drug development. Further, we are keen to bring Umbralisib to Indian patients and we plan to initiate activities towards registration and approval there soon.” Pranav Amin, Chairman, Rhizen Pharmaceuticals & Managing Director of Alembic Pharmaceuticals Ltd said: “We are extremely proud of this historic milestone for Rhizen, and of the fact that Umbralisib is the first NCE discovered by Indian scientists to secure a US FDA approval. We are committed to working together with TG Therapeutics and Rhizen Pharma to ensure uninterrupted supply of UKONIQ™. Umbralisib is the first discovery asset to come out of Rhizen’s R&D efforts and this approval heralds the promise of the rest of Rhizen’s deep pipeline and continuing efforts.” About Umbralisib: Umbralisib is the first and only oral inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1 (CK1) epsilon. PI3K-delta is known to play an important role in supporting cell proliferation and survival, cell differentiation, intercellular trafficking and immunity and is expressed in both normal and malignant B-cells. CK1-epsilon is a regulator of oncoprotein translation and has been implicated in the pathogenesis of cancer cells, including lymphoid malignancies. Umbralisib is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen and for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy. These indications are approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. More information on Umbralisib or UKONIQ™ can be found at https://www.tgtherapeutics.com/prescribing-information/uspi-ukon.pdf. About Alembic Pharmaceuticals Ltd: Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic’s state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India. Alembic’s products that are marketed through a marketing team of over 5000 are well recognized by doctors and patients. Information about Alembic can be found at http://www.alembicpharmaceuticals.com/. (Reuters: ALEM.NS) (Bloomberg: ALPM) (NSE: APLL TD) (BSE: 533573) About Rhizen Pharmaceuticals A.G.: Rhizen Pharmaceuticals is an innovative, clinical-stage biopharmaceutical company focused on the discovery and development of novel onco-therapeutics. Since its establishment in 2008, Rhizen has created a diverse pipeline of proprietary drug candidates targeting several cancers and immune associated cellular pathways. Rhizen is headquartered in Basel, Switzerland. For additional information, please visit www.rhizen.com. View source version on businesswire.com:https://www.businesswire.com/news/home/20210208005742/en/ CONTACT: Samyukta Bhagwati Manager, Corporate Affairs & Communications Rhizen Pharmaceuticals AG +41 32 580 0113 [email protected] KEYWORD: EUROPE SWITZERLAND UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH FDA CLINICAL TRIALS SOURCE: Rhizen Pharmaceuticals AG Copyright Business Wire 2021. PUB: 02/08/2021 11:45 PM/DISC: 02/08/2021 11:45 PM http://www.businesswire.com/news/home/20210208005742/encenter_img Twitter Pinterest Twitter Pinterest TAGS  Local NewsBusinesslast_img read more

Read More

Comedian Kathy Griffin under fire for photo post

first_imgTourism Minister Edmund Bartlett has taken issue with an advisory by United Kingdom (UK) officials which warns British nationals to look out for possible terrorist attacks in Jamaica. The advisory was issued by Britain’s Foreign and Commonwealth Office (FCO) that has compiled a comprehensive list of all the countries in the world. The list also includes the Bahamas and the Dominican Republic as other Caribbean Islands where terrorism could occur.Newly- installed Prime Minister Dr. Hubert Minnis has issued a directive that Bahamians must try to fill all available posts before consideration is given to foreigners. Minister of Labor Dion Foulkes has acted on the order and made it clear that he has already been “very strict” in approving labor certificates for work permits and has denied or deferred several applications since taking office just over two weeks ago. Noting the Bahamas has “a serious unemployment problem”, Foulkes was adamant there would be no backing down from implementing the policy.Broward County and Kiwanis Divisions 23 and 24 have teamed up again for Christmas In July, an annual event to help homeless children in the community get ready for the ensuing school year. In addition to school-aged children, the program provides for homeless children under the age of 5. Residents and businesses in the community are invited to support this effort by donating new items for children from newborn to 19 years-of-age at collection boxes located at all Broward County Libraries and other County facilities, through Wednesday, June 28th.In SportsUsain Bolt has climbed eight places up the rankings to become the seventh most famous Athlete in the world. Bolt is the highest earning track and field athlete in history with an estimated income of approximately US$30m annually. Only Real Madrid footballer, Cristiano Ronaldo, American basketballer LeBron James,Argentinian footballer Lionel Messi, Swiss tennis player Roger Federer, American golfer Phil Mickelson and Brazil striker Neymar are ranked higher than Bolt in the second annual ESPN World Fame list.Here’s What’s Trending.American entertainer Kathy Griffin has received tremendous criticism for recently posting a photo of herself holding what appeared to be a bloody, severed head of President Donald Trump. Negative reaction to the photo has also cost her gig as CNN’s co-host of its New Year’s Eve Live program with CNN’s Anderson Cooper. She has also since lost sponsors for shows and several promoters have canceled her appearances. Griffin critics included Chelsea Clinton daughter of 2016 Democratic presidential candidate Hillary Clinton.For Tomorrow’s weather forecastIt will be mostly cloudy with showers likely in Broward, Miami-Dade, and Palm Beach Counties, with a high of 88 and a low of 77 degrees. Today’s news was brought to you by the Florida Department of Health in Broward County, who encourages you to Protect Your Baby, Vaccinate On Time, Every Time. They remind you that Immunizations are SAFE, PROVEN PROTECTION. For more on these and other stories visit us at caribbeannationalweekly.com Make sure to pick your copy of Caribbean News weekly at your nearest Caribbean American outlet.last_img read more

Read More